Karyopharm Therapeutics (KPTI) traded down -5.13 % during a 24 hours period ending at 11:46 PM Central Europe on Monday 26th. One Karyopharm Therapeutics stock can currently be bought for about USD 0.48 on popular exchanges. Current supply of Karyopharm Therapeutics stocks is 22.7 mn. Karyopharm Therapeutics has a current market capitalization of USD 11.7 mn and approximately USD 1 mn worth of Karyopharm Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Karyopharm Therapeutics has traded -70.06 % down. Simple moving average of last 200 days is at USD 6.22. The highest price of past 52 weeks was recorded at USD 10.99 on 02/24/2026. 52 weeks low was at USD 0.31 on 10/15/2026.
Here is how related stocks have performed in the past 24 hours:
Good Times Restaurants (GTIM) traded down -1.53 % and now trades at USD 1.28. Current market capitalisation for Good Times Restaurants is USD 13.6 mn. Current price/earnings ratio for Good Times Restaurants is 6.13.
Pasithea Therapeutics (KTTA) traded down -8.99 % and now trades at USD 0.4. Current market capitalisation for Pasithea Therapeutics is USD 13.5 mn.
Hain Celestial (HAIN) traded down -6.25 % and now trades at USD 0.15. Current market capitalisation for Hain Celestial is USD 13.7 mn.
Biocardia (BCDA) traded down -1.08 % and now trades at USD 0.9. Current market capitalisation for Biocardia is USD 13.9 mn.
Allarity Therapeutics (ALLR) traded up 2.13 % and now trades at USD 0.92. Allarity Therapeutics has a market capitalisation of USD 13.8 mn.
About Karyopharm Therapeutics
Karyopharm Therapeutics Inc. is an oncology-focused pharmaceutical company operating in the health care sector, specializing in biotechnology. The company offers combination therapies with dexamethasone for patients with pretreated multiple myeloma, as well as providing single-agent and combination activity against a variety of human cancers. Karyopharm Therapeutics serves patients in the United States, Germany, and Israel, and its official website is www.karyopharm.com . The company went public on the Nasdaq stock exchange on November 6, 2013.
